ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 2,890.00
+85.00 (3.03%)
At close: Sep 4, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 263.97 billion as of September 4, 2026. Its market cap has decreased by -35.99% in one year.
Market Cap
263.97B
Enterprise Value
170.84B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,890.00
ChartMarket Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 263.97B, a decrease of -51.79%. That is a compound annual growth rate of -43.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 263.97B | -72.66% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 279.71B |
| DAE HWA Pharmaceutical | 201.91B |
| Vivozon Pharmaceutical | 186.51B |
| GC WellBeing | 185.67B |
| NOVAREX | 180.11B |
| Cosmax Nbt | 176.36B |
| CellBion | 164.54B |
| Kyung Dong Pharmaceutical | 149.72B |